Tuberculosis News and Research

Latest Tuberculosis News and Research

Antimalarial medicines in African countries are substandard, says QAMSA study

The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria.

10 Feb 2010

TBTC to receive more than $90 million to develop effective tuberculosis treatments

The Tuberculosis Trials Consortium (TBTC) strives to conduct research about the diagnosis, medical treatment, and prevention of tuberculosis (TB) infection and disease. The network is composed of a partnership of clinical investigators from the U.S. Centers for Disease Control and Prevention (CDC), public health departments from different countries, as well as medical and pharmaceutical institutions.

10 Feb 2010

Mutations that enable Pseudomonas to thrive in cystic fibrosis lung secretions may also guard them against antibiotics

People with cystic fibrosis, an inherited disease that clogs airways with thick mucous, frequently have lung infections that defy treatment. While the life expectancy for children with cystic fibrosis has increased over the past few decades, many lives are still shortened in young adulthood by the ravages of lung infections.

10 Feb 2010

G7 forgives Haiti's bilateral loans to support aid effort

At a press conference on Saturday, "Canadian Finance Minister Jim Flaherty said he and his G-7 colleagues would forgive bilateral loans extended to poverty-stricken Haiti, which estimates it could have lost 200,000 residents in the major earthquake that hit last month," Dow Jones Newswires reports.

10 Feb 2010

CQ examines concerns over Obama's FY2011 global health budget

Congressional Quarterly examines concerns among health advocates and international development experts about what President Obama's FY 2011 budget request might mean to U.S. commitments to particular diseases abroad, such as HIV/AIDS, tuberculosis and malaria.

9 Feb 2010

Scientists employ new approach to understand metabolic changes of TB bacteria

The complex chain of metabolic events in bacteria that lead to fatal diseases such as tuberculosis (TB) may be better understood using mathematical models, according to an article published in the February issue of Microbiology Today.

5 Feb 2010

Recent releases in Global Health

A Lancet study examines childbirth practices and the relationship between these practices and maternal and perinatal outcomes in nine Asian countries, as assessed by a WHO global survey. Based on the analysis of over 107,000 deliveries, the authors conclude, "To improve maternal and perinatal outcomes, caesarean section should be done only when there is a medical indication" (Lumbiganon et al., 2/6). These findings "should help us to prioritise our strategies to reduce unnecessary interventions in childbirth," write the authors of a Lancet comment.

5 Feb 2010

Global cancer rates could be reduced by 40% with prevention strategies, report says

"Forty percent of the 12 million people diagnosed with cancer worldwide each year could avert the killer disease by protecting themselves against infections and changing their lifestyles, experts said on Tuesday," Reuters reports.

4 Feb 2010

Mycobacterium avium infection can result in three different kinds of illness in humans

Through work carried out in connection with her PhD, Tone Bjordal Johansen has shown that Mycobacterium avium does not infect pigs via birds, as previously believed. M. avium can be divided into several subspecies, and the research shows that birds are infected by one particular subspecies, whereas pigs and humans are infected by another.

4 Feb 2010

MV vaccine prevents TB in people with HIV infection

Results from clinical trials conducted in Tanzania show that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. Findings from the trials, which were conducted by investigators from Dartmouth Medical School in the United States, will be published in the next issue of AIDS, the leading journal in the field of HIV and AIDS research. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

3 Feb 2010

Obama's FY 2011 budget gives global health funding boost

President Barack Obama's FY 2011 budget request for global health totals $9.6 billion and includes funding for global health activities within the State Department, USAID and HHS, the Wall Street Journal reports

3 Feb 2010

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

Researchers at National Jewish Health have discovered how the virulent food-borne bacteria Listeria monocytogenes induces infected immune cells to sabotage their own defensive response.

2 Feb 2010

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

The development of antibiotics gave physicians seemingly miraculous weapons against infectious disease. Effective cures for terrible afflictions like pneumonia, syphilis and tuberculosis were suddenly at hand. Moreover, many of the drugs that made them possible were versatile enough to knock out a wide range of deadly bacterial threats.

2 Feb 2010

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

New vaccine effective in preventing TB in HIV patients

Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection.

30 Jan 2010

Recent releases in Global Health

Rajiv Shah's appointment as USAID administrator "comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies," write the authors of a Lancet Comment that examines the U.S. Global Hunger and Food Security Initiative. Though the initiative "sends a clear message to the world about U.S. intent to partner with poor nations to achieve their national food and nutrition goals … the Initiative's nutrition plan, unlike its detailed agricultural blueprint, currently lacks a comprehensive set of aims, activities, research needs, and programme benchmarks," the authors write.

29 Jan 2010

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

Bill and Melinda Gates announced today that their foundation will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world's poorest countries.

29 Jan 2010

Recipients of the 2010 Media Awards for Health Reporting announced

The Canadian Nurses Association (CNA) and the Canadian Medical Association (CMA) today announced the recipients of the 2010 Media Awards for Health Reporting, Canada's premier health journalism awards.

27 Jan 2010

WHO Director-General highlights global health gains, challenges at executive board meeting

During the WHO's recent executive board meeting, WHO Director-General Margaret Chan reflected on public health gains over the past decade and the challenges that lie ahead, Nigeria's Guardian reports. Chan commended the international community's response to H1N1 and global efforts to reduce child mortality, fight malaria and tuberculosis.

27 Jan 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

Antimalarial medicines in African countries are substandard, says QAMSA study

TBTC to receive more than $90 million to develop effective tuberculosis treatments

Mutations that enable Pseudomonas to thrive in cystic fibrosis lung secretions may also guard them against antibiotics

G7 forgives Haiti's bilateral loans to support aid effort

CQ examines concerns over Obama's FY2011 global health budget

Scientists employ new approach to understand metabolic changes of TB bacteria

Recent releases in Global Health

Global cancer rates could be reduced by 40% with prevention strategies, report says

Mycobacterium avium infection can result in three different kinds of illness in humans

MV vaccine prevents TB in people with HIV infection

Obama's FY 2011 budget gives global health funding boost

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

New vaccine effective in preventing TB in HIV patients

Recent releases in Global Health

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

Recipients of the 2010 Media Awards for Health Reporting announced

WHO Director-General highlights global health gains, challenges at executive board meeting

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in